Structure of enzyme seen as target for ALS drugs

September 13, 2014

Investigators from the School of Medicine at The University of Texas Health Science Center at San Antonio have determined the first high-resolution structure of an enzyme that, if partially inhibited, could represent a new way to treat most cases of amyotrophic lateral sclerosis.